GLEOSTINE vs IMDELLTRA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. GLEOSTINE and IMDELLTRA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GLEOSTINE	IMDELLTRA
Rating	70/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LOMUSTINE	TARLATAMAB-DLLE
Manufacturer	Azurity	Amgen Inc
Dosage forms	Capsule	Kit
Drug class	Alkylating Drug	—
Boxed warning	Boxed warning	Boxed warning
Half-life	about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug	—
Treats	Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease	Lung Neoplasms

gleostine imdelltra

Rating

70/100

72/100

Pharmacy pays

—

Type

Active ingredient

LOMUSTINE

TARLATAMAB-DLLE

Manufacturer

Azurity

Amgen Inc

Dosage forms

Capsule

Kit

Drug class

Alkylating Drug

—

Boxed warning

Half-life

about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug

—

Treats

Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease

Lung Neoplasms

Frequently asked questions

Which is better-rated, Gleostine or Imdelltra?

By our independent rating, Imdelltra scores higher — 3.6 vs 3.5 out of 5 for Gleostine. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Gleostine and Imdelltra?

Gleostine contains Lomustine, while Imdelltra contains Tarlatamab-Dlle — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.